Over my 13-year tenure at Gilead Sciences, I have consistently pursued opportunities to tackle complex, high-impact challenges. I began in Clinical Operations as a Clinical Project Assistant and advanced to Clinical Trial Lead of some of our largest Phase 3 clinical trials. Recognizing the need for operational efficiency, I transitioned to the Systems and Process team. Since 2022, I have been a key contributor in the Portfolio Strategy and Analytics group, my work focuses on maximizing portfolio value and reporting. In 2025, I am also supporting an enterprise-wide initiative focused on improving decision making at Gilead.
I am excited about the opportunity to bring my unique skill set to Jade Biosciences, a dynamic and fast-growing organization. I thrive on solving problems and driving impact, and I am eager to contribute to a start-up environment where agility and innovation are paramount.